One thousand five hundred and thirty-six patients with Ph+ CP-CML were analyzed for blast increase and ACA, 1510 patients were cytogenetically evaluable. The gene discussed is CP; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.